| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/17/2009 | WO2009150686A1 Liposomes capable of effectively binding the beta amyloid peptide |
| 12/17/2009 | WO2009150651A1 Injectable hydrogel forming chitosan mixtures |
| 12/17/2009 | WO2009150543A2 Conjugated vi saccharides |
| 12/17/2009 | WO2009150371A2 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors |
| 12/17/2009 | WO2009150284A2 Apo-a conjugates for the administration of biologically active compounds |
| 12/17/2009 | WO2009150278A1 Pharmaceutical composition of melphalan |
| 12/17/2009 | WO2009150257A2 Compositions for treating rosacea |
| 12/17/2009 | WO2009150194A1 Telaprevir dosing regimen |
| 12/17/2009 | WO2009149955A2 Method for the selection of a suitable adjuvant for the production of solid dispersions for pharmaceutical formulations |
| 12/17/2009 | WO2009149553A1 Modified protein excipient for delayed-release tablet |
| 12/17/2009 | WO2009149540A1 Controllable synthesis of porous carbon spheres, and electrochemical applications thereof |
| 12/17/2009 | WO2009149537A1 Injectable polymer-lipid blend |
| 12/17/2009 | WO2009130517A3 Method and compound for tracking micrometastases of prostate androgen receptors |
| 12/17/2009 | WO2009117410A3 Formation of nanostructured particles of poorly water soluble drugs and recovery by mechanical techniques |
| 12/17/2009 | WO2009105548A3 Methods for treating and diagnosing diabetes |
| 12/17/2009 | WO2009082607A3 Targeting lipids |
| 12/17/2009 | WO2009082606A3 Folate-irna conjugates |
| 12/17/2009 | WO2009071899A3 Supramolecular handcuffs in polymeric architecture |
| 12/17/2009 | WO2008117125A3 Compositions capable of facilitating penetration across a biological barrier |
| 12/17/2009 | US20090312441 Organic compounds |
| 12/17/2009 | US20090312440 Agent for improving tissue penetration |
| 12/17/2009 | US20090312439 Use of roll compacted pyrogenically produced silicon dioxide in pharmaceutical compositions |
| 12/17/2009 | US20090312259 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 12/17/2009 | US20090311406 Products containing smart foam and method of making |
| 12/17/2009 | US20090311337 Biodegradable particle and method for producing the same |
| 12/17/2009 | US20090311329 Casein micelles for nanoencapsulation of hydrophobic compounds |
| 12/17/2009 | US20090311327 Oral Therapeutic Compound Delivery System |
| 12/17/2009 | US20090311325 Enhancing solubility and dissolution rate of poorly soluble drugs |
| 12/17/2009 | US20090311324 Polymer matrix, method for its production, and its use |
| 12/17/2009 | US20090311312 Transdermal Hormone Delivery System: Compositions And Methods |
| 12/17/2009 | US20090311299 Antithrombotic coating for drug eluting medical devices |
| 12/17/2009 | US20090311295 Particles with high uniform loading of nanoparticles and methods of preparation thereof |
| 12/17/2009 | US20090311290 Urogenital or anorectal transmucosal vaccine delivery system |
| 12/17/2009 | US20090311218 Novel mutant interferon-alpha protein, particularly interferon-alpha subtype alpha 8; provides agents for susceptive diseases superior in anti-viral and anti-tumor actions compared with conventional agents for susceptive diseases; agents against tumors, viral diseases, and infection diseases |
| 12/17/2009 | US20090311208 Oil In Silicone Emulsions and Compositions Containing Same |
| 12/17/2009 | US20090311182 Macromolecular Delivery Systems for Non-Invasive Imaging, Evaluation and Treatment of Arthritis and Other Inflammatory Diseases |
| 12/17/2009 | US20090311179 Selective Targeting of Apoptotic Cells |
| 12/17/2009 | CA2731138A1 Compositions for treating rosacea |
| 12/17/2009 | CA2728248A1 Telaprevir dosing regimen |
| 12/17/2009 | CA2727825A1 Pegylated insulin lispro compounds |
| 12/17/2009 | CA2727811A1 Conjugates for the administration of biologically active compounds |
| 12/17/2009 | CA2727605A1 Povidone iodine, a novel alternative preservative for ophthalmic compositions |
| 12/17/2009 | CA2727588A1 Injectable hydrogel forming chitosan mixtures |
| 12/17/2009 | CA2727565A1 Conjugated vi saccharides |
| 12/17/2009 | CA2727488A1 Tablet quickly disintegrating in the oral cavity and method for producing the same |
| 12/17/2009 | CA2727417A1 Liposomes capable of effectively binding the beta amyloid peptide |
| 12/17/2009 | CA2726700A1 Modified protein excipient for delayed-release tablet |
| 12/17/2009 | CA2726616A1 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug |
| 12/17/2009 | CA2726076A1 Peptide analogs of alpha-melanocyte stimulating hormone |
| 12/17/2009 | CA2725827A1 Controllable synthesis of porous carbon spheres, and electrochemical applications thereof |
| 12/17/2009 | CA2725530A1 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors |
| 12/17/2009 | CA2725482A1 Controlled release formulations of pramipexole |
| 12/16/2009 | EP2133325A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 12/16/2009 | EP2133099A2 Conjugated biological molecules and their preparation |
| 12/16/2009 | EP2133098A1 G-CSF conjugates |
| 12/16/2009 | EP2133097A1 Transpulmonary liposome for controlling drug arrival |
| 12/16/2009 | EP2133096A2 Oral disintegrating tablet |
| 12/16/2009 | EP2133092A1 Oral vaccine |
| 12/16/2009 | EP2133084A2 Pharmaceutical Formulation Comprising Lanthanum Compounds |
| 12/16/2009 | EP2133073A1 Poly(lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar |
| 12/16/2009 | EP2133070A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 12/16/2009 | EP2133068A1 Method for selecting a suitable excipient for producing solid dispersions for pharmaceutical formulas |
| 12/16/2009 | EP2132260A2 Material for the formation of structures having a support function |
| 12/16/2009 | EP2132173A1 Formulations for cathepsin k inhibitors |
| 12/16/2009 | EP2132133A1 Particulate drug delivery |
| 12/16/2009 | EP2131867A2 Modified hydroxypolymer conjugates with killing effect on tumor cells |
| 12/16/2009 | EP2131866A2 Dual acting prodrugs |
| 12/16/2009 | EP2131864A2 Angiogenic composition |
| 12/16/2009 | EP2131857A2 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition |
| 12/16/2009 | EP2131855A2 A conjugate of insulin and vitamin b12 for oral delivery |
| 12/16/2009 | EP2131831A1 Conjugated fatty acids and poly-l-lysine for combating pathogenic micro-organisms |
| 12/16/2009 | EP2131822A1 Divalent metal-ion loaded nano-transport system having a dendritic architecture useful for therapy |
| 12/16/2009 | EP2131821A1 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 12/16/2009 | EP2131809A2 Methods and compositions for normalizing meibomian gland secretions |
| 12/16/2009 | EP2131808A1 Implant containing destructurized starch |
| 12/16/2009 | EP1434603B1 Method of treatment using ligand-immunogen conjugates |
| 12/16/2009 | EP1425028B1 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 12/16/2009 | EP1287147B1 Immunotoxin fusion proteins and means for expression thereof |
| 12/16/2009 | EP0824541B1 Nucleic acid ligand complexes |
| 12/16/2009 | CN101605548A Liposome encapsulated poly-ICLC method to prophylactically treat an avian influenza viral infection |
| 12/16/2009 | CN101605546A Method for prevention of discoloration with time of donepezil-containing skin adhesive preparation |
| 12/16/2009 | CN101605545A Skin adhesive preparation comprising stabilized donepezil |
| 12/16/2009 | CN101605537A Benzoyl peroxyde comprising compositions, at least one naphtoic acid derivative and at least one compound of polyurethane polymer-type or derivatives thereof, and their use |
| 12/16/2009 | CN101605535A Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| 12/16/2009 | CN101605533A Process for preparation of a stable dispersion of solid amorphous submicron particles in an aqueous medium |
| 12/16/2009 | CN101605532A Protein formulations containing sorbitol |
| 12/16/2009 | CN101605531A Ophthalmic compositions containing a synergistic combination of three polymers |
| 12/16/2009 | CN101605530A Pharmaceutical formulations and methods for making the same |
| 12/16/2009 | CN101602865A Ethylcellulose mixed suspension liquid and preparation method and application thereof |
| 12/16/2009 | CN101602791A Integrin receptor target lipidosome drug carrier, preparation method and application thereof |
| 12/16/2009 | CN101601862A Application of porous starch and derivatives thereof as medicament carrier |
| 12/16/2009 | CN101601842A Health care product for relieving and preventing ocular diseases and preparation method thereof |
| 12/16/2009 | CN101601797A Patch for treating chronic bronchitis and manufacturing method thereof |
| 12/16/2009 | CN101601796A Chinese medicinal fuming-steaming composition for treating arthralgia syndrome, and guiding medicament thereof |
| 12/16/2009 | CN101601795A Patch for treating hypertension |
| 12/16/2009 | CN101601791A Double-face external patch for treating habitual constipation |
| 12/16/2009 | CN101601774A Double-face external patch for treating hypertension |
| 12/16/2009 | CN101601762A Medicine for treating diarrhea |
| 12/16/2009 | CN101601759A Double-face external patch for treating diarrhea |
| 12/16/2009 | CN101601755A Double-face external patch for treating chronic bronchitis |